RevMAB
Pre-clinicalUnlock the potential of recombinant monoclonal antibodies with Revmab. Explore our anti-idiotypic monoclonal antibody development service today!
Founded
2016
Focus
Antibodies
About
Unlock the potential of recombinant monoclonal antibodies with Revmab. Explore our anti-idiotypic monoclonal antibody development service today!
Funding History
1Total raised: $5M
Seed$5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2016
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile